2003
Low-Dose Fluvoxamine Treatment of Children and Adolescents with Pervasive Developmental Disorders: A Prospective, Open-Label Study
Martin A, Koenig K, Anderson GM, Scahill L. Low-Dose Fluvoxamine Treatment of Children and Adolescents with Pervasive Developmental Disorders: A Prospective, Open-Label Study. Journal Of Autism And Developmental Disorders 2003, 33: 77-85. PMID: 12708582, DOI: 10.1023/a:1022234605695.Peer-Reviewed Original ResearchConceptsPervasive developmental disorderSelective serotonin reuptake inhibitor responseOpen-label studyOpen-label trialLow-dose fluvoxamineDevelopmental disordersPremature discontinuationClinical responseFluvoxamine treatmentPartial respondersMean ageSerotonin levelsSelect childrenPubertal statusInhibitor responseBehavioral activationFluvoxamineChildrenFurther investigationDisordersTreatmentGender differencesAdolescentsSubjectsTolerability
1999
Obsessive-Compulsive Symptoms in Prader-Willi and “Prader-Willi—Like” Patients
State M, Dykens E, Rosner B, Martin A, King B. Obsessive-Compulsive Symptoms in Prader-Willi and “Prader-Willi—Like” Patients. Journal Of The American Academy Of Child & Adolescent Psychiatry 1999, 38: 329-334. PMID: 10087695, DOI: 10.1097/00004583-199903000-00021.Peer-Reviewed Original ResearchConceptsPrader-Willi syndromeObsessive-compulsive symptomsManagement of BehavioralGroup of patientsMeasures of obesitySymptom-related impairmentOC symptomsGreater symptom severityFood-related problemsClinic patientsPrader-WilliPatientsSymptomsSymptom severityObesityDevelopmental delayGenetic abnormalitiesPWS groupMaladaptive behaviorsChromosome 15PWS genotypeSyndromeBehavioral phenotypesPWS critical regionProximal long arm
1998
SSRIs FOR “DIFFICULT” TEMPERAMENT
Landau J, Martin A, Burke M. SSRIs FOR “DIFFICULT” TEMPERAMENT. Journal Of The American Academy Of Child & Adolescent Psychiatry 1998, 37: 1008-1009. PMID: 9785709, DOI: 10.1097/00004583-199810000-00007.Peer-Reviewed Original Research